The Majority of Adrenocorticotropin Receptor (Melanocortin 2 Receptor) Mutations Found in Familial Glucocorticoid Deficiency Type 1 Lead to Defective Trafficking of the Receptor to the Cell Surface
Open accessThe DOI matches its Crossref record; 36 of the 36 references it cites were found in a registry or an index.
Abstract
CONTEXT: There are at least 24 missense, nonconservative mutations found in the ACTH receptor [melanocortin 2 receptor (MC2R)] that have been associated with the autosomal recessive disease familial glucocorticoid deficiency (FGD) type 1. The characterization of these mutations has been hindered by difficulties in establishing a functional heterologous cell transfection system for MC2R. Recently, the melanocortin 2 receptor accessory protein (MRAP) was identified as essential for the trafficking of MC2R to the cell surface; therefore, a functional characterization of MC2R mutations is now possible. OBJECTIVE: Our objective was to elucidate the molecular mechanisms responsible for defective MC2R function in FGD. METHODS: Stable cell lines expressing human MRAPalpha were established and transiently transfected with wild-type or mutant MC2R. Functional characterization of mutant MC2R was performed using a cell surface expression assay, a cAMP reporter assay, confocal microscopy, and coimmunoprecipitation of MRAPalpha. RESULTS: Two thirds of all MC2R mutations had a significant reduction in cell surface trafficking, even though MRAPalpha interacted with all mutants. Analysis of those mutant receptors that reached the cell surface indicated that four of six failed to signal, after stimulation with ACTH. CONCLUSION: The majority of MC2R mutations found in FGD fail to function because they fail to traffic to the cell surface.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Indeed, naturally occurring homozygous mutations of Asp 103 and 107 in MC2R, the equivalent conserved Asp residues in this receptor, lead to ACTH resistance/Familial Glucocorticoid Deficiency (47).”
From ACTH Antagonists (2016) · cites this paper as [47]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The cloning of a family of genes that encode the melanocortin receptors
Mountjoy, K. G., Robbins, L. S., Mortrud, M. T., & Cone, R. D. (1992) · Science · doi:10.1126/science.1325670 · Cited by 1,635 · cited 1×
“MC2R is one of five melanocortin receptors (MCRs) ( 8 ).”
BackgroundSequence Alignment of the G-Protein Coupled Receptor Superfamily
PROBST, W. C., SNYDER, L. A., SCHUSTER, D. I., BROSIUS, J., & SEALFON, S. C. (1992) · DNA and Cell Biology · doi:10.1089/dna.1992.11.1 · Cited by 845 · cited 1×
“This is an interesting mutation because it lies in the asparagine-argininetyrosine (DRY) region in the second intracellular loop, which is themostconservedregionofallGPCRs(20).Indeed,thearginine residue in this motif is the only amino acid conserved among all subclass 1 receptors ( 21 ).”
BackgroundTherapeutic approaches to protein-misfolding diseases
Cohen, F. E., & Kelly, J. W. (2003) · Nature · doi:10.1038/nature02265 · Cited by 800 · cited 1×
“Receptor ligands or enzyme inhibitors, which selectively recognize the mutant proteins and rescue conformational mutants, are referred to as pharmacological chaperones, and these present promising therapeutic avenues (33, 34 ).”
BackgroundQuality control in the endoplasmic reticulum protein factory
Sitia, R., & Braakman, I. (2003) · Nature · doi:10.1038/nature02262 · Cited by 688
Influence of molecular and chemical chaperones on protein folding
Welch, W. J., & Brown, C. R. (1996) · Cell Stress & Chaperones · doi:10.1379/1466-1268(1996)001<0109:iomacc>2.3.co;2 · Cited by 495 · cited 1×
“Thesesmallmolecules,namedchemicalchaperones,arethought to nonselectively stabilize mutant proteins and facilitate their folding ( 32 ).”
BackgroundMetherell, L. A., Chapple, J. P., Cooray, S., David, A., Becker, C., Rüschendorf, F., Naville, D., Begeot, M., Khoo, B., Nürnberg, P., et al. (2005) · Nature Genetics · doi:10.1038/ng1501 · Cited by 437 · cited 2×
“Interaction of mutated MC2R with MRAP was assessed by Co-IP and immunoblotting as previously described ( 13 , 14) CHO cells were transiently transfected with MRAP-Flag, and mutant HA-MC2R constructsand24haftertransfection,cellswerelysedwith0.1% D-dodecyl- -maltoside in PBS in the presence of protease inhibitors.”
BackgroundMethodThe Highly Conserved DRY Motif of Class A G Protein-Coupled Receptors: Beyond the Ground State
Rovati, G. E., Capra, V., & Neubig, R. R. (2007) · Molecular Pharmacology · doi:10.1124/mol.106.029470 · Cited by 392 · cited 1×
“Interestingly, substitution of the next amino acid in the DRY motif, the Y129C mutant, caused significantintracellularretention.Tyrosineistheleastconservedof the triad sequence, and in other GPCRs, this tyrosine mutation often only marginally affects receptor function, if at all ( 23 ).”
BackgroundMechanisms of cell death in rhodopsin retinitis pigmentosa: implications for therapy
Mendes, H. F., van der Spuy, J., Chapple, J. P., & Cheetham, M. E. (2005) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2005.02.007 · Cited by 377 · cited 1×
“trafficking defects. These include rhodopsin mutations in retinitis pigmentosa ( 28 ), vasopressin 2 receptor mutations causing nephrogenic diabetes insipidus (29), and GnRH receptor point mutationscausinghypogonadotrophichypogonadism(30).The strict quality control mechanisms within cells ensure that improperly folded…”
BackgroundPharmacological chaperones: potential treatment for conformational diseases
Bernier, V., Lagacé, M., Bichet, D. G., & Bouvier, M. (2004) · Trends in Endocrinology & Metabolism · doi:10.1016/j.tem.2004.05.003 · Cited by 283 · cited 1×
“trafficking defects. These include rhodopsin mutations in retinitis pigmentosa (28), vasopressin 2 receptor mutations causing nephrogenic diabetes insipidus ( 29 ), and GnRH receptor point mutationscausinghypogonadotrophichypogonadism(30).The strict quality control mechanisms within cells ensure that improperly folded…”
BackgroundClark, A. J. L., Grossman, A., & McLoughlin, L. (1993) · The Lancet · doi:10.1016/0140-6736(93)90208-x · Cited by 272
Adrenocorticotropin insensitivity syndromes
Clark, A. J. L., & Weber, A. (1998) · Endocrine Reviews · doi:10.1210/edrv.19.6.0351 · Cited by 234
Self-citationJanovick, J. A. (2002) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.87.7.3255 · Cited by 194
Tsigos, C., Arai, K., Hung, W., & Chrousos, G. P. (1993) · Journal of Clinical Investigation · doi:10.1172/jci116853 · Cited by 182
A common step for signal transduction in G protein-coupled receptors
Oliveira, L., Paiva, A. C. M., Sander, C., & Vriend, G. (1994) · Trends in Pharmacological Sciences · doi:10.1016/0165-6147(94)90137-6 · Cited by 151 · cited 1×
“This is an interesting mutation because it lies in the asparagine-argininetyrosine (DRY) region in the second intracellular loop, which is themostconservedregionofallGPCRs( 20 ).Indeed,thearginine residue in this motif is the only amino acid conserved among all subclass 1 receptors (21).”
BackgroundSHEPARD, T. H. (1959) · A.M.A. Journal of Diseases of Children · doi:10.1001/archpedi.1959.02070010156002 · Cited by 149
Effects of Recombinant Agouti-Signaling Protein on Melanocortin Action
Yang, Y.-K. (1997) · Molecular Endocrinology · doi:10.1210/me.11.3.274 · Cited by 140
Swords, F. M., Baig, A., Malchoff, D. M., Malchoff, C. D., Thorner, M. O., King, P. J., Hunyady, L., & Clark, A. J. L. (2002) · Molecular Endocrinology · doi:10.1210/me.2002-0099 · Cited by 109
Modulation of GDP Release from Transducin by the Conserved Glu134-Arg135 Sequence in Rhodopsin
Acharya, S., & Karnik, S. S. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.41.25406 · Cited by 107
Weber, A. (1995) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.80.1.65 · Cited by 98 · cited 2×
“I44M was described in a Finnish girl by Weber et al. ( 6 ), as a compound heterozygous mutation in combination with L192fs.”
BackgroundNoon, L., Franklin, J., King, P., Goulding, N., Hunyady, L., & Clark, A. (2002) · Journal of Endocrinology · doi:10.1677/joe.0.1740017 · Cited by 88
Self-citationInherited ACTH insensitivity illuminates the mechanisms of ACTH action
Clark, A. J. L., Metherell, L. A., Cheetham, M. E., & Huebner, A. (2005) · Trends in Endocrinology & Metabolism · doi:10.1016/j.tem.2005.10.006 · Cited by 82
Self-citationN�thiger, F. (1967) · European Journal of Pediatrics · doi:10.1007/bf00517818 · Cited by 77
The function of a highly-conserved arginine residue in activation of the muscarinic M1 receptor
JONES, P. G., CURTIS, C. A. M., & Hulme, E. C. (1995) · European Journal of Pharmacology Molecular Pharmacology · doi:10.1016/0922-4106(95)90036-5 · Cited by 76 · cited 2×
“... three are located in the extracellular domain of MC2R (Fig. 3B), consistent with the hypothesis that these mutations may lead to failure ofligandbinding.Interestingly,oneofthetrafficking-competent mutations located within the second intracellular loop of the MC2R is the R128 substitution (R128C), which lies within…”
BackgroundZhu, S. Z., Wang, S. Z., Hu, J., & El‐Fakahany, E. E. (1994) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)10025-4 · Cited by 74
Cooray, S. N., Almiro Do Vale, I., Leung, K.-Y., Webb, T. R., Chapple, J. P., Egertová, M., Cheetham, M. E., Elphick, M. R., & Clark, A. J. L. (2008) · Endocrinology · doi:10.1210/en.2007-1463 · Cited by 73
Self-citationElias, L. L. K., Huebner, A., Pullinger, G. D., Mirtella, A., & Clark, A. J. L. (1999) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.84.8.5924 · Cited by 68 · cited 3×
“Previous functional studies performed for a variety of mutations such as G116V (26), R137W (27), R146H (6, 10 ), T159K (10), C251F (19), and Y254C (27) all found that there was impaired receptor signaling when stimulated with ACTH and low affinity for ACTH binding.”
BackgroundInfluentialFlück, C. E., Martens, J. W. M., Conte, F. A., & Miller, W. L. (2002) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2002-020501 · Cited by 57 · cited 2×
“Previous functional studies performed for a variety of mutations such as G116V (26), R137W (27), R146H (6, 10), T159K (10), C251F (19), and Y254C ( 27 ) all found that there was impaired receptor signaling when stimulated with ACTH and low affinity for ACTH binding.”
BackgroundSlawik, M., Reisch, N., Zwermann, O., Maser-Gluth, C., Stahl, M., Klink, A., Reincke, M., & Beuschlein, F. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-032010 · Cited by 54
Protein Origami: Therapeutic Rescue of Misfolded Gene Products
Conn, P. M. (2002) · Molecular Interventions · doi:10.1124/mi.2.5.308 · Cited by 54 · cited 1×
“Receptor ligands or enzyme inhibitors, which selectively recognize the mutant proteins and rescue conformational mutants, are referred to as pharmacological chaperones, and these present promising therapeutic avenues ( 33 , 34).”
BackgroundElias, L. L. K. (1999) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.84.8.2766 · Cited by 50
Expression of the human melanocortin-2 receptor in different eukaryotic cells
Rached, M., Mourabit, H. E., Buronfosse, A., Blondet, A., Naville, D., Bégeot, M., & Penhoat, A. (2005) · Peptides · doi:10.1016/j.peptides.2004.11.037 · Cited by 40
HEREDITARY ADRENOCORTICAL UNRESPONSIVENESS TO ACTH
Franks, R. C., & Nance, W. E. (1970) · PEDIATRICS · doi:10.1542/peds.45.1.43 · Cited by 39
Heterogeneity in the molecular basis of ACTH resistance syndrome.
Collares, C. V. A., Antunes‐Rodrigues, J., Moreira, A. C., Nesi-França, S., Pereira, L. A., Soares, M. M. S., Elías, J., Clark, A., de Castro, M., & Elias, L. L. K. (2008) · European Journal of Endocrinology · doi:10.1530/eje-08-0079 · Cited by 33
Characterization of the human acth receptor gene andin vitroexpression
Naville, D., Penhoat, A., Barjhoux, L., Jaillard, C., Fontanay, S., Saez, J., Durand, P., & Bégeot, M. (1996) · Endocrine Research · doi:10.1080/07435809609043716 · Cited by 21
Tsiotra, P. C., Koukourava, A., Kaltezioti, V., Geffner, M. E., Naville, D., Bégeot, M., Raptis, S., & Tsigos, C. (2006) · Journal of Pediatric Endocrinology and Metabolism · doi:10.1515/jpem.2006.19.9.1157 · Cited by 14
Characterization of Cell Lines Stably Expressing Human Normal or Mutated EGFP-Tagged MC4R
Blondet, A. (2004) · The Journal of Biochemistry · doi:10.1093/jb/mvh064 · Cited by 11 · cited 1×
“The discovery of MRAP now provides the opportunity to characterize fully the MC2R in readily transfected and maintained cell lines, such as Chinese hamster ovary (CHO) and human embryonic kidney 293 (HEK293) cells, both of which are known not to endogenously express MCR, and to be unresponsive to ACTH and Nle4, D-Phe7…”
Background
Cited by
Marinko, J. T., Huang, H., Penn, W. D., Capra, J. A., Schlebach, J. P., & Sanders, C. R. (2019) · Chemical Reviews · doi:10.1021/acs.chemrev.8b00532 · Cited by 252
The Year In G Protein-Coupled Receptor Research
Millar, R. P., & Newton, C. L. (2010) · Molecular Endocrinology · doi:10.1210/me.2009-0473 · Cited by 167
Phenotypic characteristics of familial glucocorticoid deficiency (FGD) type 1 and 2
Chung, T. L. L., Chan, L. F., Metherell, L. A., & Clark, A. J. L. (2010) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2009.03663.x · Cited by 92
MOLECULAR EVOLUTION OF GPCRS: Melanocortin/melanocortin receptors
Dores, R. M., Londraville, R. L., Prokop, J., Davis, P., Dewey, N., & Lesinski, N. (2014) · Journal of Molecular Endocrinology · doi:10.1530/jme-14-0050 · Cited by 92
Familial glucocorticoid deficiency: New genes and mechanisms
Meimaridou, E., Hughes, C. R., Kowalczyk, J., Guasti, L., Chapple, J. P., King, P., Chan, L. F., Clark, A., & Metherell, L. (2012) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2012.12.010 · Cited by 95
Metadata
- Authors
- Chung, T. T., Webb, T. R., Chan, L. F., Cooray, S. N., Metherell, L. A., King, P. J., Chapple, J. P., & Clark, A. J. L.
- Affiliations
- Queen Mary University of London (GB)
- Corresponding author
- Clark, A. J. L.
- Venue
- The Journal of Clinical Endocrinology & Metabolism
- Publisher
- The Endocrine Society
- Published
- 2008-12-01
- Volume
- 93
- Issue
- 12
- Pages
- 4948-4954
- ISSN
- 0021-972X (ISSN-L)
- 1945-7197
- PMC
- PMC2635546
- OpenAlex
- W2018717551
- Cited by
- 82
- References
- 36
- Citations by year
- 2026: 1 · 2025: 2 · 2024: 4 · 2023: 8 · 2022: 4 · 2021: 3 · 2020: 3 · 2019: 5 · 2018: 4 · 2017: 3 · 2016: 5 · 2015: 2 · 2014: 10 · 2013: 7 · 2012: 5
- FWCI
- 3.86
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- The Journal of Clinical Endocrinology & Metabolism (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adrenal Hormones and Disorders
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Receptor Mechanisms and Signaling
- Life Sciences › Neuroscience › Behavioral Neuroscience › Stress Responses and Cortisol
- Keywords
- melanocortin 2 receptor, ACTH receptor, missense mutations, receptor trafficking, cell surface expression, MRAP, ACTH signaling, cAMP signaling, autosomal recessive disorder
- MeSH terms
- Cyclic AMP, Animals, Cell Line, Cricetulus, Glucocorticoids, Cricetinae, Humans, Ligands, Receptors, Cell Surface, Blotting, Western, Signal Transduction, Mutagenesis, Site-Directed, CHO Cells, Genes, Reporter, Microscopy, Confocal, Mutation, Missense, LDL-Receptor Related Protein-Associated Protein, Receptor, Melanocortin, Type 2, Immunoprecipitation
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.